Try our beta test site

Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.
ClinicalTrials.gov Identifier:
NCT00564421
First received: November 27, 2007
Last updated: March 23, 2017
Last verified: March 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 14, 2008
  Primary Completion Date: February 14, 2008 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: May 20, 2011